doxapram and amoxapine

doxapram has been researched along with amoxapine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Andersson, JA; Chauhan, S; Chopra, AK; Dann, SM; Fitts, EC; Kirtley, ML; Motin, VL; Peniche, AG; Ponnusamy, D; Rosenzweig, JA; Sha, J1
Andersson, JA; Boonma, P; Chopra, AK; Dann, SM; Galindo, CL; Luna, RA; Peniche, AG; Savidge, TC; Sha, J1

Reviews

1 review(s) available for doxapram and amoxapine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for doxapram and amoxapine

ArticleYear
New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Amoxapine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Clostridioides difficile; Disease Models, Animal; Doxapram; Drug Administration Schedule; Drug Repositioning; Enterocolitis, Pseudomembranous; Female; High-Throughput Screening Assays; Macrophages; Mice; Plague; Prescription Drugs; Salmonella Infections; Salmonella typhimurium; Small Molecule Libraries; Survival Analysis; Trifluoperazine; Yersinia pestis

2016
New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection.
    mBio, 2020, 03-10, Volume: 11, Issue:2

    Topics: Amoxapine; Animals; Clostridioides difficile; Clostridium Infections; Doxapram; Drug Repositioning; Female; Immunity, Innate; Immunomodulation; Male; Mice; Mice, Inbred C57BL; Microbiota; RNA-Seq; Specific Pathogen-Free Organisms; Trifluoperazine

2020